South Korea-based LOTTE Biologics, a contract development and manufacturing (CDMO) organisation, and Alvotech, a global ...
Andelyn Biosciences (“Andelyn”), a leading US-based patient-focused cell and gene therapy Contract Developme...
Vitalant, one of the nation’s largest nonprofit blood and biotherapies healthcare organisations, has announced the...
Cell and gene therapies may now be moving faster than the manufacturing networks built to deliver them. The Alliance of...
Germfree, a full-lifecycle engineering and manufacturing partner for mission-critical environments across life sciences,...
Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company advancing blood- and cell-based therapies ...
SK pharmteco, a subsidiary of SK Inc., the strategic investment company for SK Group, South Korea’s second-la...
Vetter, a leading Contract Development and Manufacturing Organization (CDMO), continues to expand its commercial fill-an...
Piramal Pharma Solutions (PPS), India-based Contract Development and Manufacturing Organization (CDMO) and part of Piram...
Germfree, a full-lifecycle engineering and manufacturing partner for mission-critical environments across life sciences,...
China-based Sanyou Biopharmaceuticals and NovoCodex Biopharmaceuticals have jointly announced that the two companies hav...
WuXi XDC Cayman Inc., a leading global Contract Research, Development and Manufacturing Organisation (CRDMO) focused on ...
India-based Gujarat Themis Biosyn Limited (GTBL) has announced the completion of the acquisition of 100% equity sharehol...
WuXi XDC Cayman Inc., a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specialisi...
Shilpa Biologicals, an India-based integrated biologics development and manufacturing organisation, has announced an exc...
Viral Vector Manufacturing Facility (VVMF), Australia’s first viral vector Contract Development and Manufacturing ...
Novo Holdings, a leading global healthcare and life sciences investor, has announced a strategic minority investment in ...
Bracco Imaging has expanded its BubbleGen cell selection portfolio with the launch of the BubbleGen CD3+ T Cell Selectio...
Japan-based Hodogaya Chemical has established a subsidiary to promote the nucleic acid therapeutics CDMO business. In it...
South Korea-based Samsung Bioepis has announced the marketing approval of Ustekinumab BS Intravenous Infusion 130mg...
South Korea-based Samsung Biologics, a leading contract development and manufacturing organization (CDMO), has anno...
Cell Therapies has manufactured and released the first clinical dose for the KOALA trial, a first-in-human study evaluat...
Strides Pharma Science has received an Establishment Inspection Report from the United States Food and Drug Administrati...
Asia-Pacific continues to attract investment across pharmaceutical manufacturing, biotechnology, vaccines, advanced ther...
AsymBio, a China-based biologics-focused Contract Development and Manufacturing Organization (CDMO) and a subsidiary of ...
